GSK PLC GSK shares inched up 0.04% to £13.34 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.05% to 8,199.11. Supported ...

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" as we look toward 2025.

A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...

Another player who Indiana could part ways with is veteran guard Erika Wheeler. The former All-Star is also going to be an ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

GSK’s Arexvy is currently approved in the United States, Europe, Japan and several other countries for adults aged 60 and ...

As 2024 draws to a close, we explore five stocks to buy for a new year that promises opportunity alongside uncertainty ...

Dr. Leah Smith, PharmD and Dr. Lisa Smith, PharmD, explain why if you are 50 years or older, you should ask your pharmacist about your risk and about vaccination.